Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York
CEO Michael Halstead to participate in a fireside chat on Friday, September 11, 2026 at 8:00 a.m.
EDT.
NEW YORK and TORONTO, Sept.
03, 2026 (GLOBE NEWSWIRE) — Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.